Personas / Equipo Humano

Belen Arranz Martí

Buscador de publicaciones

Publicaciones

  • Sanchez-Autet M, Alfonso M, Hernandez C, Gonzalez-Blanco L, García-Portilla MP, Bernardo M, Anmella G, Amoretti S, Safont G and Arranz B.

    Predictive value of C-reactive protein and hematologic ratios for metabolic syndrome in schizophrenia.

    Spanish Journal of Psychiatry and Mental Health . : .

    [doi:10.1016/j.sjpmh.2025.11.006]

  • Anmella G, Amoretti S, Safont G, Meseguer A, Vieta E, Pons-Cabrera MT, Alfonso M, Hernández-Cera C, Sanchez-Autet M, Pérez-Baldellou F, González-Blanco L, García-Portilla MP, Bernardo M and Arranz B.

    Intestinal permeability and low-grade chronic inflammation in schizophrenia: A multicentre study on biomarkers. Rationale, objectives, protocol and preliminary results.

    Spanish Journal of Psychiatry and Mental Health . 18(4): 281-287. Nº de citas: 3

    [doi:10.1016/j.sjpmh.2023.09.005]

  • Safont G, Garriga M, González-Rodríguez A, Amoretti S, Simón O, Solè E, Garcia-Rizo C, Arranz B, Vieta E and Bernardo M.

    Maternity in women with schizophrenia and schizoaffective disorder

    Spanish Journal of Psychiatry and Mental Health . 18(2): 106-110. Nº de citas: 7

    [doi:10.1016/j.sjpmh.2023.04.002]

  • Safont G, Garriga M, Amoretti S, Cuesta MJ, Parellada M, González-Pinto A, Bergé D, Rodriguez-Jimenez R, Bejarano AR, Sarró S, Ibáñez Á, Usall J, Gutiérrez M, Vieta E, Arranz B, Berrocoso E, Verdolini N and Bernardo M.

    Sex and substance use in first episode psychosis: Impact on clinical symptoms, psychosocial functioning and cognitive performance

    Spanish Journal of Psychiatry and Mental Health . 18(2): 80-90. Nº de citas: 2

    [doi:10.1016/j.rpsm.2022.03.002]

  • San L, Arranz B, Romans C, García B, Coromina M, Ortiz S, Vilaplana M, Soto V, Ruth Villaescusa Portella and Alvarós J.

    Patient-reported outcome measures to assess mental and physical health status, functionality, and quality of life in patients with major depression or schizophrenia

    Journal of Patient-Reported Outcomes . 9(1): 4-4. Nº de citas: 3

    [doi:10.1186/s41687-024-00804-x]

  • Ballasch I, López-Molina L, Galán-Ganga M, Sancho-Balsells A, Rodríguez-Navarro I, Borràs-Pernas S, Rabadan MA, Chen W, Pastó-Pellicer C, Flotta F, Maoyu W, Fernández-Irigoyen J, Santamaría E, Aguilar R, Dobaño C, Egri N, Hernandez C, Alfonso M, Juan M, Alberch J, Del Toro D, Arranz B, Canals JM and Giralt A.

    Alterations of the IKZF1-IKZF2 tandem in immune cells of schizophrenia patients regulate associated phenotypes

    Journal of Neuroinflammation . 21(1): 326-326.

    [doi:10.1186/s12974-024-03320-3]

  • González-Blanco L, Dal Santo F, García-Portilla MP, Alfonso M, Hernández C, Sánchez-Autet M, Anmella G, Amoretti S, Safont G, Martín-Hernández D, Malan-Müller S, Bernardo M and Arranz B.

    Intestinal permeability biomarkers in patients with schizophrenia: Additional support for the impact of lifestyle habits

    EUROPEAN PSYCHIATRY . 67(1): . Nº de citas: 9

    [doi:10.1192/j.eurpsy.2024.1765]

  • Ibáñez D, Condominas E, Haro JM, Vázquez IG, Radar-Mdd-Spain, Bailón R, Garcia E, Kontaxis S, Peñarrubia-María MT, Arranz B, Llaosa-Scholten R, Gardeñes L, Hotopf M, Matcham F, Lamers F, Penninx BWJH, Annas P, Folarin A, Narayan V, Antunes R and Siddi S.

    Pre- and post-COVID 19 outbreak relationship between physical activity and depressive symptoms in Spanish adults with major depressive disorder: a secondary analysis of the RADAR-MDD cohort study.

    Frontiers in Psychology . 15: 1436611-1436611.

    [doi:10.3389/fpsyg.2024.1436611]

  • Radua J, Fortea L, Goikolea JM, Zorrilla I, Bernardo M, Arrojo M, Cunill R, Castells X, Becoña E, López-Durán A, Torrens M, Tirado-Muñoz J, Fonseca F, Arranz B, Garriga M, Sáiz PA, Flórez G, San L and González-Pinto A.

    Meta-analysis of the effects of adjuvant drugs in co-occurring bipolar and substance use disorder.

    Revista de Psiquiatria y Salud Mental . 17(4): . Nº de citas: 4

    [doi:10.1016/j.rpsm.2023.01.005]

  • de la Fuente-Tomás L, Arranz B, Sierra P, Sánchez-Autet M, García-Blanco A, Gutiérrez-Rojas L, Balanzá-Martínez V, Vidal-Rubio S, Vieta E, Jiménez E, Hernández C, Arrojo M, Gómez-Trigo J, Zapico-Merayo Y, Pelayo-Terán JM, Pérez-Solà V, Mur E, Cardoner N, González-Pinto A, Zorrilla I, Ruiz-Veguilla M, Catalán-Barragán R, Safont G, Martínez-Cao C, Sáiz P, Bobes J and García-Portilla MP.

    Spanish validation of the Empirically Developed Clinical Staging Model (EmDe-5) for patients with bipolar disorder.

    Revista de Psiquiatria y Salud Mental . 17(4): 215-221. Nº de citas: 1

    [doi:10.1016/j.rpsm.2021.09.005]